Caricamento...
Repositioning Salirasib as a new antimalarial agent
Malaria is a serious tropical disease that kills thousands of people every year, mainly in Africa, due to Plasmodium falciparum infections. Salirasib is a promising cancer drug candidate that interferes with the post-translational modification of Ras. This S-farnesyl thiosalicylate inhibits isopreny...
Salvato in:
| Pubblicato in: | Medchemcomm |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Royal Society of Chemistry
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6836747/ https://ncbi.nlm.nih.gov/pubmed/31803400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/c9md00298g |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|